About Us
About hVIVO
Leadership Team
Our Companies
History
Services
Human Challenge Trials
RSV
Influenza
COVID-19
HRV
Malaria
Asthma & COPD
hMPV
Laboratory Services
Clinical Trial Recruitment
Clinical Trial Site Services
Vaccine Phase II-III Trials
Respiratory Clinical Trials
Articles & Research
News & Media
Regulatory News
Media Coverage
Media Press Kit
Media Library
Events
Investors
Investors
Regulatory News & Email Alerts
Results Centre
Share Price Information
Events & Presentations
Environmental, Social & Governance
AIM Rule 26
Advisors
Documents
Corporate Governance
Volunteers
Careers
Contact Us
Contact Us
Company Documents
Watch hVIVO’s July 2024 Capital Markets Day
here
Home
•
Company Documents
12 May 2025
2025 AGM Proxy
Read more
12 May 2025
2025 AGM Notice
Read more
10 Apr 2025
Annual Report 2024
Read more
15 Apr 2024
2024 AGM Proxy
Read more
15 Apr 2024
2024 AGM Notice
Read more
15 Apr 2024
Annual Report 2023
Read more
28 Apr 2023
2023 AGM Notice
Read more
28 Apr 2023
Annual Report 2022
Read more
13 Oct 2022
Articles of Association
Read more
10 Jun 2022
2022 AGM Notice
Read more
18 Jun 2021
Croft Nominees Trust Undertaking
Read more
13 Apr 2021
Open Orphan Circular
Read more
13 Apr 2021
2021 AGM Notice
Read more
26 Jun 2020
2020 AGM Notice
Read more
26 May 2020
Open Orphan Circular
Read more
09 Dec 2019
Open Orphan hVIVO Admission Document
Read more
09 Dec 2019
Open Orphan hVIVO Circular
Read more
12 Sep 2019
2019 AGM Notice
Read more
19 Jun 2019
Open Orphan Venn Circular
Read more
19 Jun 2019
Open Orphan Venn Admission Document
Read more
04 Oct 2016
VENN Innovenn Circular
Read more
Contact our Investor Relations team.
IR@hVIVO.com
angle-down
meetup
chevron-down
arrow-up
